Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €80.49 EUR
Change Today -1.24 / -1.52%
Volume 0.0
0MJA On Other Exchanges
Symbol
Exchange
Berlin
New York
As of 3:40 PM 07/27/15 All times are local (Market data is delayed by at least 15 minutes).

mead johnson nutrition co (0MJA) Snapshot

Open
€81.04
Previous Close
€81.73
Day High
€81.94
Day Low
€79.97
52 Week High
04/10/15 - €97.08
52 Week Low
08/1/14 - €67.65
Market Cap
16.3B
Average Volume 10 Days
16.5
EPS TTM
--
Shares Outstanding
202.7M
EX-Date
06/18/15
P/E TM
--
Dividend
€1.61
Dividend Yield
1.67%
Current Stock Chart for MEAD JOHNSON NUTRITION CO (0MJA)

mead johnson nutrition co (0MJA) Details

Mead Johnson Nutrition Company manufactures, distributes, and sells infant formulas, children’s nutrition, and other nutritional products. It offers routine infant formula products as a breast milk substitute for healthy infants for the use as the infant’s source of nutrition, as well as a supplement to breastfeeding under the Enfamil Premium, Enfapro Premium, Enfamil A+, and Enfalac A+ names; and solutions products to address common feeding tolerance problems, including spit-up, fussiness, gas, and lactose intolerance under the Enfamil Gentlease and Enfamil A.R names. The company also provides specialty formula products, including formulas for addressing various conditions or special medical needs, such as cow’s milk protein and multiple other food allergies, premature and low birth weight infants, and premature babies at home, as well as produces medical foods for nutritional management of individuals under the Nutramigen, Puramino, Enfamil Premature, and EnfaCare. In addition, it offers children’s nutrition products comprising products for meeting children’s nutritional needs at toddlers and older children stage, as well as offer milk modifiers under the Enfagrow, ChocoMilk, and Cal-C-Tose names; a range of other products, including pre-natal and post-natal nutritional supplements for expectant and nursing mothers under the Expecta and EnfaMama names; and pediatric vitamin under the Enfamil Poly-Vi-Sol name, as well as multivitamins and iron supplements. The company sells its products to mothers, health care professionals, and retailers in approximately 50 countries in North America, Europe, Asia, and Latin America. Mead Johnson Nutrition Company was founded in 1905 and is headquartered in Glenview, Illinois.

7,700 Employees
Last Reported Date: 02/27/15
Founded in 1905

mead johnson nutrition co (0MJA) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $1.0M
Interim Chief Financial Officer, Senior Vice ...
Total Annual Compensation: $551.0K
Senior Vice President of Technical Operations
Total Annual Compensation: $407.5K
Compensation as of Fiscal Year 2014.

mead johnson nutrition co (0MJA) Key Developments

Mead Johnson Nutrition Company Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2015; Reaffirms Capital Spending Guidance for the Full Year of 2015

Mead Johnson Nutrition Company announced unaudited consolidated earnings results for the second quarter and six months ended June 30, 2015. For the quarter, the company reported net sales of $1,032.4 million compared to $1,111.1 million a year ago. Earnings before interest and income taxes were $229.2 million compared to $244.9 million a year ago. Earnings before income taxes were $215.3 million compared to $229.6 million a year ago. Net earnings were $162.6 million compared to $176.1 million a year ago. Net earnings attributable to shareholders were $162.9 million or $0.80 per diluted share compared to $171.4 or $0.84 per diluted share million a year ago. For the six months, the company reported net sales of $2,126.8 million compared to $2,224.4 million a year ago. Earnings before interest and income taxes were $514.4 million compared to $536.1 million a year ago. Earnings before income taxes were $486.7 million compared to $508.4 million a year ago. Net earnings were $369.7 million compared to $383.9 million a year ago. Net earnings attributable to shareholders were $370.3 million or $1.82 per diluted share compared to $373.8 or $1.84 per diluted share million a year ago. Net cash provided by operating activities was $456.5 million compared to $304.0 million a year ago. Capital expenditures were $80.0 million compared to $94.8 million a year ago. Debt stood at $1.5 billion as of June 30, 2015, with its net debt position close to 0. For the full year of 2015, capital spending expectations remain unchanged at around $175 million. This is in line with its long-term goal of about 4% of sales. Depreciation and amortization expense is expected to be around $100 million for the full year. On a full year basis, the company expects the non-GAAP effective tax rate to be approximately 24%.

Mead Johnson Nutrition Company Provides Earnings Guidance for the Second Quarter and Six Months of 2015 and Revises Earnings Guidance for the Year 2015

Mead Johnson Nutrition Company provided earnings guidance for the second quarter and six months of 2015 and revised earnings guidance for the year 2015. For the quarter, the company expects preliminary second quarter constant dollar sales were 3% below the prior year quarter. Including the impact of foreign currency, preliminary reported sales were 7% below the prior year quarter. Strong sales of the recently launched imported products to China were insufficient to fully offset declines in the China based manufactured products. Hong Kong cross-border sales stabilized, but were below prior year levels. Preliminary non-GAAP and GAAP EPS for the second quarter of 2015 are expected to be $0.76 and $0.80, respectively, impacted by the sales decline and increased Advertising & Promotion expenditure. Net sales expected to be $1,032 million. For the six months, the company expects preliminary year-to-date sales were in-line with the prior year on a constant-dollar basis and 4% lower on a reported basis. Slowing emerging market growth and dairy costs approaching five-year lows drove competitive promotional price discounting across several MJN markets in Latin America and Asia, most notably in China. For the year 2015, the company expects annual sales growth to be in the range of 0% to 2% on a constant-dollar basis, previously estimated at 7%. Including the estimated impact of foreign exchange, reported sales are expected to be 2% to 4% below the prior year, previously estimated to be 2% above the prior year. Full-year non-GAAP EPS is expected to be in the range of $3.63 to $3.78, previously estimated at $3.90 to $4.00. Specified Items are currently expected to be $0.07 per share, excluding any future mark-to-market pension adjustment. As a result, full-year GAAP EPS guidance is expected to be in the range of $3.56 to $3.71, previously estimated at $3.79 to $3.89.

Mead Johnson Nutrition Company Announces Management Changes

Mead Johnson Nutrition Company announced that Michel Cup will join the company as Executive Vice President and Chief Financial Officer (CFO) effective September 1, 2015. Mr. Cup, 45, will assume responsibility for Mead Johnson’s global finance function and information systems and management. He will also oversee the company’s external development efforts. Mr. Cup was most recently the CFO of D.E. Master Blenders 1753. Mr. Cup will take over from Charles Urbain, who currently serves as the company’s Interim CFO. Effective September 1, 2015, Mr. Urbain will assume a newly created role as Executive Vice President and Chief Operating Officer. In his new role, Mr. Urbain will be responsible for leading the company’s global commercial operations and its external affairs function.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
0MJA:GR €80.49 EUR -1.24

0MJA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Biostime International Holdings Ltd $15.22 HKD +0.22
Inner Mongolia Yili Industrial Group Co Ltd CNY17.05 CNY +0.13
Perrigo Co PLC $193.60 USD +7.10
Hain Celestial Group Inc/The $67.01 USD -0.88
Yakult Honsha Co Ltd ¥7,230 JPY +90.00
View Industry Companies
 

Industry Analysis

0MJA

Industry Average

Valuation 0MJA Industry Range
Price/Earnings 25.5x
Price/Sales 4.2x
Price/Book 24.1x
Price/Cash Flow 25.5x
TEV/Sales 3.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEAD JOHNSON NUTRITION CO, please visit www.meadjohnson.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.